Literature DB >> 27377716

Extranodal diffuse large B-cell lymphoma (DLBCL) and primary mediastinal B-cell lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

U Vitolo1, J F Seymour2, M Martelli3, G Illerhaus4, T Illidge5, E Zucca6, E Campo7, M Ladetto8.   

Abstract

Entities:  

Year:  2016        PMID： 27377716     DOI： 10.1093/annonc/mdw175

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  29 in total

1.  Parsaclisib, a potent and highly selective PI3Kδ inhibitor, in patients with relapsed or refractory B-cell malignancies.

Authors:  Andres Forero-Torres; Radhakrishnan Ramchandren; Abdulraheem Yacoub; Michael S Wertheim; William J Edenfield; Paolo Caimi; Martin Gutierrez; Luke Akard; Carolina Escobar; Justin Call; Daniel Persky; Swaminathan Iyer; Douglas J DeMarini; Li Zhou; Xuejun Chen; Fitzroy Dawkins; Tycel J Phillips
Journal:  Blood       Date:  2019-02-25       Impact factor: 22.113

Review 2.  Primary central nervous system lymphoma: essential points in diagnosis and management.

Authors:  Semra Paydas
Journal:  Med Oncol       Date:  2017-03-17       Impact factor: 3.064

Review 3.  Tailoring front-line therapy in diffuse large B-cell lymphoma: who should we treat differently?

Authors:  Andrew Davies
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2017-12-08

4.  Unilateral Tonsillar Swelling as a Manifestation of Diffuse Large B Cell Lymphoma (DLBCL): Case Report.

Authors:  Wulyo Rajabato; Vitya Chandika; Agnes Stephanie Harahap
Journal:  Maedica (Bucur)       Date:  2021-12

5.  The dangers of déjà vu: memory B cells as the cells of origin of ABC-DLBCLs.

Authors:  Leandro Venturutti; Ari M Melnick
Journal:  Blood       Date:  2020-11-12       Impact factor: 22.113

6.  Bulky primary tibia mantle cell lymphoma achieved complete remission with CHOP and DHAP plus rituximab: A case report.

Authors:  Si Chen; Meng Ye
Journal:  Oncol Lett       Date:  2018-08-29       Impact factor: 2.967

7.  Chemoradiotherapy with temozolomide after high-dose methotrexate for primary CNS lymphoma: a multicenter phase I study of a response-adapted strategy.

Authors:  Silvia Chiesa; Stefan Hohaus; Lorenzo Falcinelli; Francesco D'Alò; Massimo Fabrizio Martelli; Stefania Manfrida; Francesco Beghella Bartoli; Cesare Colosimo; Vincenzo Valentini; Cynthia Aristei; Mario Balducci
Journal:  Ann Hematol       Date:  2020-08-20       Impact factor: 3.673

Review 8.  Primary Pancreatic Lymphoma: Recommendations for Diagnosis and Management.

Authors:  Davide Facchinelli; Enrico Boninsegna; Carlo Visco; Cristina Tecchio
Journal:  J Blood Med       Date:  2021-05-05

9.  Real-world data on treatment and outcomes of patients with primary mediastinal large B-cell lymphoma: a Swedish lymphoma register study.

Authors:  Tove Wästerlid; Sverker Hasselblom; Joel Joelsson; Caroline E Weibull; Georgios Rassidakis; Birgitta Sander; Karin E Smedby
Journal:  Blood Cancer J       Date:  2021-05-21       Impact factor: 11.037

Review 10.  Antibody Therapies for Large B-Cell Lymphoma.

Authors:  Mattia Novo; Elisa Santambrogio; Pio Manlio Mirko Frascione; Delia Rota-Scalabrini; Umberto Vitolo
Journal:  Biologics       Date:  2021-05-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.